Skip to main content
profile image
Selected Works of Steven Borzak, MD, FACC
Article
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial
American Heart Journal (2007)
  • Adam B. Greenbaum, Ford Motor Company
  • E. Magnus Ohman, Durham University
  • C. Michael Gibson, Beth Israel Deaconess Medical Center
  • Steven Borzak, Florida Cardiovascular Research, LC, Atlantis, FL
  • Amanda L. Stebbins, Durham University
  • Mei Lu, Ford Motor Company
  • Michel R. Le May, University of Ottawa
  • Jill E. Stankowski, Loughborough University
  • Hakan Emanuelsson, Loughborough University
  • W. Douglas Weaver, Ford Motor Company
Link
Disciplines
Publication Date
October 1, 2007
DOI
10.1016/J.AHJ.2007.06.001
Citation Information
Adam B. Greenbaum, E. Magnus Ohman, C. Michael Gibson, Steven Borzak, et al.. "Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial" American Heart Journal Vol. 154 Iss. 4 (2007) p. 702 - 709
Available at: http://works.bepress.com/steven-borzak/40/